About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Ongoing studies

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Recruiting

3 1 1
Investigated drugs:
- Efgartigimod Alfa
+8
Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+2
Study on Mechanical Thrombectomy and Acetylsalicylic Acid for Patients with Acute Ischemic Stroke from Large Vessel Blockage

Recruiting

3 1 1 1 1
Investigated drugs:
- Acetylsalicylic Acid
Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

Recruiting

1 1 1
Investigated drugs:
- Momelotinib Dihydrochloride Monohydrate
+7
Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated drugs:
+4
Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Recruiting

3 1 1 1
Investigated drugs:
+5
Study of Elafibranor for Adults with Primary Biliary Cholangitis

Recruiting

3 1
Investigated diseases:
- Primary biliary cholangitis
Investigated drugs:
- Elafibranor
+8
Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Recruiting

2 1
Investigated diseases:
- Heart failure with reduced ejection fraction
Investigated drugs:
- Jtt-861 Monohydrochloride Dihydrate
Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Recruiting

3 1 1 1
Investigated drugs:
+7

#1 Clinical Trials Search in Europe

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie Ul. Dr. Kazimierza Jaczewskiego 8, Lublin, 20-090, Poland

About Specializations

Medical Center localisation

Ongoing studies

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Study on Mechanical Thrombectomy and Acetylsalicylic Acid for Patients with Acute Ischemic Stroke from Large Vessel Blockage

Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie Ul. Dr. Kazimierza Jaczewskiego 8, Lublin, 20-090, Poland

About Specializations

Medical Center localisation

Ongoing studies

We use cookies